air polymer type A intrauterine device

Action and Spectrum

Actions and Spectrum: 

ExEm Foam gel when visualized with ultrasound, it appears echogenic or bright, which helps distinguish and locate the foam within the fallopian tubes and peritoneal cavity. This visibility allows healthcare professionals to assess the condition of these structures and aid in diagnostic procedures or treatments. 

Drug Interaction

Adverse Reaction

Frequency not defined 

Pelvic pain
Abdominal pain  

Vasovagal reactions 

Post-procedure spotting 

Black Box Warning

Black Box Warning: 

None. 

Contraindication / Caution

Contraindication/Caution: 

• Hypersensitivity 
• Infection 
• Inflammation 
• Pregnancy 
• Uterine abnormalities 
• Medical history 
• Adverse reactions 

Pregnancy / Lactation

Pregnancy consideration:  

Contraindicated during pregnancy 

Breastfeeding warnings:  

Data is unavailable regarding the presence of drug in breast milk.  

Pregnancy category: 

Category A: well-controlled and satisfactory studies show no risk to the fetus in the first or later trimester. 

Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women. 

Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.    

Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.    

Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.    

Category N: No data is available for the drug under this category. 

Pharmacology

Pharmacology:  

ExEm Foam does not have direct pharmacological effects; it is an echogenic contrast agent during ultrasound examinations. The foam’s echogenicity or brightness aids in visualizing the fallopian tubes and peritoneal cavity, assisting healthcare professionals in diagnosing and evaluating the condition of these structures. 

Pharmacodynamics: 

The pharmacodynamics of the individual components in ExEm Foam, such as hydroxyethyl cellulose and glycerin, may have separate considerations. For example, hydroxyethyl cellulose, as a polymer, contributes to the viscosity and stability of the foam. Glycerin, on the other hand, acts as a humectant and helps maintain moisture in the application area. 

Pharmacokinetics: 

No literature is available. 

Adminstartion

Administration: 

• Preparation: Review the patient’s medical history, gather necessary equipment, and ensure a sterile environment. 
• Patient Positioning: Position the patient on an examination table in a lithotomy position (lying on their back with knees bent and legs apart). 
• Sterility and Cleansing: Use sterile gloves, drapes, and disinfectants to maintain sterility. Cleanse the vaginal and cervical areas. 
• Foam Administration: Load ExEm Foam into an intrauterine applicator or catheter. Gently insert the applicator into the cervix and advance it into the uterine cavity. Release the foam into the uterine cavity. 
• Visualization: Perform ultrasound imaging to visualize the fallopian tubes and peritoneal cavity. The foam’s echogenic appearance enhances visibility. 
• Monitoring and Removal: Monitor the patient for immediate adverse reactions or complications. Remove the foam from the uterine cavity using the applicator or appropriate methods. 

Patient Information Leaflet

Patient information leaflet 

Generic Name: air polymer type A intrauterine device 

Why do we use air polymer type A intrauterine devices? 

It is a specialized medical product used for gynecology and reproductive medicine diagnostic purposes. It is designed explicitly as an echogenic contrast agent for ultrasound imaging of the fallopian tubes and peritoneal cavity.